MAPT and tauopathy: Similar to the effects we observed with the expression of anti-tau intrabodies prior to overt tauopathy, expressing the anti-tau intrabody selective for proteasomal mediated degradation displayed effects on decreasing pathological tau in aged P301S-tg mice.